Practice Patterns and Opinions in the Treatment of Acanthamoeba Keratitis : Cornea

Secondary Logo

Journal Logo

Clinical Science

Practice Patterns and Opinions in the Treatment of Acanthamoeba Keratitis

Oldenburg, Catherine E MPH; Acharya, Nisha R MD, MS; Tu, Elmer Y MD; Zegans, Michael E MD; Mannis, Mark J MD; Gaynor, Bruce D MD; Whitcher, John P MD, MPH; Lietman, Thomas M MD; Keenan, Jeremy D MD, MPH

Author Information
Cornea 30(12):p 1363-1368, December 2011. | DOI: 10.1097/ICO.0b013e31820f7763



Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis.


An online survey was sent to all subscribers of The Cornea Society via the kera-net listserv. Descriptive statistics were performed.


Eighty-two participants completed the online survey. Of the 82 respondents, 76.8% included the combination of clinical examination and culture in their diagnostic strategy and 43.9% used confocal microscopy. Most respondents (97.6%) had used combination therapy with multiple agents to treat acanthamoeba keratitis at some point in the past, whereas a smaller proportion (47.6%) had ever used monotherapy. Respondents most commonly chose polyhexamethylene biguanide as the ideal choice for monotherapy (51.4%), and dual therapy with a biguanide and diamidine as the ideal choice for combination therapy (37.5%). The majority of respondents (62.2%) reported using topical corticosteroids at least some of the time for acanthamoeba keratitis. Keratoplasty was an option considered by most respondents (75.6%), although most (85.5%) would only perform surgery after medical treatment failure.


There was a wide range of current practice patterns for the diagnosis and treatment of acanthamoeba keratitis. The lack of sufficiently powered comparative effectiveness studies and clinical trials makes evidence-based decision-making for this disease difficult.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid